company background image
300972 logo

Fujian Wanchen Biotechnology Group SZSE:300972 Stock Report

Last Price

CN¥76.75

Market Cap

CN¥13.8b

7D

5.2%

1Y

112.0%

Updated

24 Dec, 2024

Data

Company Financials +

Fujian Wanchen Biotechnology Group Co., Ltd.

SZSE:300972 Stock Report

Market Cap: CN¥13.8b

300972 Stock Overview

Fujian Wanchen Biotechnology Co., Ltd engages in the research and development, cultivation, production, and sale of edible fungi in China. More details

300972 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth6/6
Past Performance2/6
Financial Health5/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Fujian Wanchen Biotechnology Group Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Fujian Wanchen Biotechnology Group
Historical stock prices
Current Share PriceCN¥76.75
52 Week HighCN¥83.80
52 Week LowCN¥17.69
Beta-0.036
1 Month Change20.13%
3 Month Change143.19%
1 Year Change111.96%
3 Year Change362.63%
5 Year Changen/a
Change since IPO181.14%

Recent News & Updates

Fujian Wanchen Biotechnology Group's (SZSE:300972) Strong Earnings Are Of Good Quality

Nov 04
Fujian Wanchen Biotechnology Group's (SZSE:300972) Strong Earnings Are Of Good Quality

Fujian Wanchen Biotechnology Group Co., Ltd. (SZSE:300972) Stock Rockets 28% But Many Are Still Ignoring The Company

Oct 01
Fujian Wanchen Biotechnology Group Co., Ltd. (SZSE:300972) Stock Rockets 28% But Many Are Still Ignoring The Company

Return Trends At Fujian Wanchen Biotechnology Group (SZSE:300972) Aren't Appealing

Sep 30
Return Trends At Fujian Wanchen Biotechnology Group (SZSE:300972) Aren't Appealing

Recent updates

Fujian Wanchen Biotechnology Group's (SZSE:300972) Strong Earnings Are Of Good Quality

Nov 04
Fujian Wanchen Biotechnology Group's (SZSE:300972) Strong Earnings Are Of Good Quality

Fujian Wanchen Biotechnology Group Co., Ltd. (SZSE:300972) Stock Rockets 28% But Many Are Still Ignoring The Company

Oct 01
Fujian Wanchen Biotechnology Group Co., Ltd. (SZSE:300972) Stock Rockets 28% But Many Are Still Ignoring The Company

Return Trends At Fujian Wanchen Biotechnology Group (SZSE:300972) Aren't Appealing

Sep 30
Return Trends At Fujian Wanchen Biotechnology Group (SZSE:300972) Aren't Appealing

We Think Fujian Wanchen Biotechnology Group (SZSE:300972) Is Taking Some Risk With Its Debt

Aug 04
We Think Fujian Wanchen Biotechnology Group (SZSE:300972) Is Taking Some Risk With Its Debt

Sentiment Still Eluding Fujian Wanchen Biotechnology Group Co., Ltd. (SZSE:300972)

Jun 06
Sentiment Still Eluding Fujian Wanchen Biotechnology Group Co., Ltd. (SZSE:300972)

Shareholder Returns

300972CN FoodCN Market
7D5.2%-3.7%-2.1%
1Y112.0%2.4%9.8%

Return vs Industry: 300972 exceeded the CN Food industry which returned 2.4% over the past year.

Return vs Market: 300972 exceeded the CN Market which returned 9.8% over the past year.

Price Volatility

Is 300972's price volatile compared to industry and market?
300972 volatility
300972 Average Weekly Movement13.9%
Food Industry Average Movement7.5%
Market Average Movement8.8%
10% most volatile stocks in CN Market13.0%
10% least volatile stocks in CN Market5.8%

Stable Share Price: 300972's share price has been volatile over the past 3 months compared to the CN market.

Volatility Over Time: 300972's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of CN stocks.

About the Company

FoundedEmployeesCEOWebsite
20114,972Li Qing Wangwww.vanchen.com

Fujian Wanchen Biotechnology Co., Ltd engages in the research and development, cultivation, production, and sale of edible fungi in China. It offers flammulina velutipes; and crab-flavored, white jade, seafood mushrooms, etc. The company was founded in 2011 and is based in Zhangpu, China.

Fujian Wanchen Biotechnology Group Co., Ltd. Fundamentals Summary

How do Fujian Wanchen Biotechnology Group's earnings and revenue compare to its market cap?
300972 fundamental statistics
Market capCN¥13.81b
Earnings (TTM)CN¥57.69m
Revenue (TTM)CN¥25.01b

239.4x

P/E Ratio

0.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300972 income statement (TTM)
RevenueCN¥25.01b
Cost of RevenueCN¥22.41b
Gross ProfitCN¥2.60b
Other ExpensesCN¥2.54b
EarningsCN¥57.69m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.32
Gross Margin10.38%
Net Profit Margin0.23%
Debt/Equity Ratio105.2%

How did 300972 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 20:50
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Fujian Wanchen Biotechnology Group Co., Ltd. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Wendan WangChina International Capital Corporation Limited
Chenghui XiongHuatai Research
Junhao FanHuatai Research